3 completed. 3 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 2 | Completed 2 |
Follow Olfaction Disorders: new trials by email Literature Review of Olfaction Disorders trials Research Report on Olfaction Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Stellate Ganglion Block for COVID-19-Induced Olfactory Dysfunction Stellate Ganglion Block - Anosmia, Hyposmia | Phase 1 / Phase 2 | Completed | Washington University School of Medicine | 20 | 2022-09-01 | 2026-02-12 |
| Preparation and Characterization Intranasal Film Loaded With Steroid as a Local Treatment of Anosmia in Compare to Insulin Intranasal Film Prednisolone - Smell Loss | Phase 1 / Phase 2 | Completed | Deraya University | 200 | 2022-03-01 | 2023-06-01 |
| The Effects of Smell on Mood and Physical Responses Exposure to relaxant and stimulant odors - Stress, Anxiety | Phase 1 | Completed | National Center for Complementary and Integrative Health (NCCIH) | 56 | 2005-08-01 | 2010-02-18 |
Anosmia (3) · Anxiety Disorders (1) · COVID-19 (1) · Depression (1)
Nervous System Diseases (3) · Neurologic Manifestations (3) · Pathological Conditions, Signs and Symptoms (3) · Sensation Disorders (3) · Signs and Symptoms (3) · Behavior (1) · Behavioral Symptoms (1) · Coronaviridae Infections (1) · Coronavirus Infections (1) · Infections (1) · Lung Diseases (1) · Mental Disorders (1) · Nidovirales Infections (1) · Pneumonia (1)
Mepivacaine (1) · Prednisolone (1)
Deraya University (1) · National Center for Complementary and Integrative Health (NCCIH) (1) · Washington University School of Medicine (1)
United States (2) · Egypt (1)
Janice Kiecolt-Glaser, PhD (1)